Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/17/1999US5939555 Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate
08/17/1999US5939550 Preparing acid-addition salt of prodrug acid of naphthyridinone antibiotic by treating ester of compound with protic acid, condensing intermediate with dipeptide, subjecting n-protected prodrug ester to acid hydrolysis
08/17/1999US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
08/17/1999US5939543 Stable solid 2-octynyl adenosine and process for producing the same
08/17/1999US5939537 Acid-functionalized saccharide monomers
08/17/1999US5939462 NPY5 receptor antagonists and methods for using same
08/17/1999US5939460 Composition comprising aromatic azines to selectively inhibit inflammation by preventing the oxidating burst from phagocytic leukocytes caused by nadph oxidase
08/17/1999US5939459 Contacting with an inflammatory mediator selected from the group consisting of pyruvate and a pyruvate precursor and is present in an amount capable of reducing the undesired inflammatory response and is an antioxidant
08/17/1999US5939456 Pulsed administration of compositions for the treatment of blood disorders
08/17/1999US5939452 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists
08/17/1999US5939451 Use of sulfonamides
08/17/1999US5939450 N,N-dimethyl-8,8-dipropyl-2-azaspiro 4.5!decane-2-propanamine dimaleate
08/17/1999US5939449 Novel compounds having high affinity for the neurotensin receptors
08/17/1999US5939447 Substituted benzopyrans
08/17/1999US5939445 Isoxazolidinediones compounds as hypoglycemic agents and treatment of arteriosclerosis
08/17/1999US5939444 Bone disorders
08/17/1999US5939443 Selective β3 adrenergic agonists
08/17/1999US5939442 Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
08/17/1999US5939440 Fungicides and bactericides
08/17/1999US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999US5939432 Thiophenes useful for modulating the adenosine receptor
08/17/1999US5939429 Cardiovascular uses of cannabinoid compounds
08/17/1999US5939427 Lotion with 17-allyl-1,4-dihydroxy-12-(2-(4-hydroxy-3-methoxy cyclohexyl)-1-methylvinyl)-23,25-dimethoxy-13,19,21,27-tetrame thyl-11,28-dioxa-4-azatricyclo(22.3.1.0(4,9))octacos-18-ene-1, 3,10,16-tetraone or salt as antiinflammatory agent
08/17/1999US5939426 Also for motion sickness and vertigo
08/17/1999US5939425 Method for treating a migraine
08/17/1999US5939424 Compounds for treating disorders of lipid metabolism and their preparation
08/17/1999US5939422 An enzyme inhibitor as bronchodilator, relaxants, antiinflammatory agent for treating asthma, allergies, inflammation, depression, dementia, diseases associated with abnormal high level of cytokine
08/17/1999US5939417 1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
08/17/1999US5939416 Inhibit ras function, use for treating tumor cells expressing an activated ras oncogene in mammals
08/17/1999US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999US5939414 Benzodiazepine hydrazide derivatives as inhibitors of HIV integrase
08/17/1999US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939410 1-carba-(dethia)-cephalosporin derivatives
08/17/1999US5939409 Processes for the production of anti-inflammatory steroids
08/17/1999US5939408 Vitamin D3 analogs
08/17/1999US5939407 Vitamin d receptors for nervous system disorders
08/17/1999US5939405 Potassium channel modulators
08/17/1999US5939404 Anticarcinogenic agents and antitumor agents
08/17/1999US5939403 Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
08/17/1999US5939402 Treating plasmodium, viral infections or parasites in mammals
08/17/1999US5939401 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
08/17/1999US5939400 DNA vaccination for induction of suppressive T cell response
08/17/1999US5939399 Polyene antibiotics, 3874 H1 to H6, processes for their preparation and use
08/17/1999US5939398 Hypocholesterolemic agents
08/17/1999US5939397 Treatment of diarrhea
08/17/1999US5939395 Isolation of phenolic compounds from aloe
08/17/1999US5939394 Treatment of allergies and autoimmune diseases, antioxidants and magnesium gluconate
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999US5939387 Insulin like growth hormone
08/17/1999US5939370 Fluoroalkviglycosiduronic acids and corresponding 6(3)-lactones, preparation and uses
08/17/1999US5939321 Mammalian tolloid-like gene and protein
08/17/1999US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds
08/17/1999US5939290 Modified sialyl Lewisx compounds
08/17/1999US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
08/17/1999US5939279 Inhibition of bacterial binding by high-mannose oligosaccharides
08/17/1999US5939277 Detection and treatment of breast and gynecological cancer
08/17/1999US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens
08/17/1999US5939260 Methods of diagnosing a predisposition for osteoarthritis via detection of vitamin D receptor gene polymorphisms
08/17/1999US5939100 Diminishing the desire of a subject to use tobacco by administering thepowdery pharmaceutical microspheres
08/17/1999US5939098 Cancer treatment with temozolomide
08/17/1999US5939095 At least one parasympathomimetically active substance and at least one parasympatholytically active substance
08/17/1999US5939094 Dosage form
08/17/1999US5939090 Gel formulations for topical drug delivery
08/17/1999US5939084 Containing glycol to dissolve melatonin; prevention of oxidative stress
08/17/1999US5939076 Composition and method for treating or alleviating migraine headaches
08/17/1999US5939072 Combination of mushroom derived polysaccharides derived from at least two types of mushrooms selected from maitake, shiitake, reishi, poria, cordyceps and hericium; treating hepatitis
08/17/1999US5939069 Inhibiting the development of insulin dependent diabetes by administering indomethacin or n-2-cyclohexlyoxynitrophenyl methanesulfonamide
08/17/1999US5939066 Treating or preventing a bacterial infection by administering a lactamase inhibitory effective amount of a penem and a lactam antibiotic
08/17/1999US5939054 Synergistic mixture of titanium oxide particles, zinc oxide particles incorporated in paste-forming oils, esters, fatty alcohols, ethers and mixtures thereof
08/17/1999US5939050 Antimicrobial compositions
08/17/1999US5937790 Anti-stress agent for animals and a method of reducing stress in animals
08/17/1999CA2195622C Process for preparing trans-piperidine-2,5-dicarboxylates
08/17/1999CA2183247C Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
08/17/1999CA2179008C 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
08/17/1999CA2152262C Process to prepare pharmaceutical compositions containing vecuronium bromide
08/17/1999CA2150867C Ultraviolet-protecting cosmeting compositions and their uses
08/17/1999CA2147594C Procedure for the obtainment of 1-(5-bromofur-2-il)-2-bromo-2-nitroethene and its microcide action
08/17/1999CA2142920C Sulfonamidodioxepanes, methods of preparation, intermediates, salts and use thereof
08/17/1999CA2136824C Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
08/17/1999CA2105180C Compositions containing sumatriptan
08/17/1999CA2098738C Controlled release oxycodone compositions
08/17/1999CA2002483C Fluoxetine analog
08/16/1999CA2247994A1 Solubilizing delivery systems and method of manufacture
08/16/1999CA2247877A1 Solubilizing delivery systems and method of manufacture
08/13/1999CA2260279A1 Transparent dandruff shampoos
08/12/1999WO1999040225A1 Immediate early genes and methods of use therefor
08/12/1999WO1999040220A2 Method of screening therapeutic agents
08/12/1999WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
08/12/1999WO1999040201A1 Protein
08/12/1999WO1999040197A2 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
08/12/1999WO1999040192A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14
08/12/1999WO1999040187A1 Nucleic acids provided for modulating cellular activation
08/12/1999WO1999040186A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
08/12/1999WO1999040117A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF
08/12/1999WO1999040110A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
08/12/1999WO1999040100A1 45 human secreted proteins
08/12/1999WO1999040099A1 5'-deoxycytidine derivatives
08/12/1999WO1999040094A1 Agent for sealing metallic ground coats, especially ground coats consisting of zinc or zinc alloys
1 ... 6459 6460 6461 6462 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 ... 7860